CLBCX
Price
$35.27
Change
-$0.35 (-0.98%)
Updated
Feb 21 closing price
Net Assets
244.57B
TASHX
Price
$14.81
Change
-$0.05 (-0.34%)
Updated
Feb 21 closing price
Net Assets
764.44M
Ad is loading...

CLBCX vs TASHX

Header iconCLBCX vs TASHX Comparison
Open Charts CLBCX vs TASHXBanner chart's image
American Funds American Balanced 529C
Price$35.27
Change-$0.35 (-0.98%)
VolumeN/A
Net Assets244.57B
Transamerica Multi-Asset Income A
Price$14.81
Change-$0.05 (-0.34%)
VolumeN/A
Net Assets764.44M
CLBCX vs TASHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CLBCX vs. TASHX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLBCX is a Hold and TASHX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
CLBCX has more cash in the bank: 245B vs. TASHX (764M). TASHX pays higher dividends than CLBCX: TASHX (3.80) vs CLBCX (1.52). CLBCX was incepted earlier than TASHX: CLBCX (23 years) vs TASHX (11 years). CLBCX is a more actively managed with annual turnover of: 171.00 vs. TASHX (37.00). CLBCX has a lower initial minimum investment than TASHX: CLBCX (250) vs TASHX (1000). TASHX annual gain was more profitable for investors over the last year : 14.67 vs. CLBCX (8.39). TASHX return over 5 years is better than : 42.94 vs. CLBCX (26.92).
CLBCXTASHXCLBCX / TASHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years11 years-
Gain YTD2.7682.82198%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets245B764M32,068%
Annual Yield % from dividends1.523.8040%
Returns for 1 year8.3914.6757%
Returns for 3 years16.4418.3190%
Returns for 5 years26.9242.9463%
Returns for 10 years53.3785.8562%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PFSI101.250.33
+0.33%
PennyMac Financial Services
ANTX1.13N/A
N/A
AN2 Therapeutics
DSGN4.91-0.10
-2.00%
Design Therapeutics
HAL26.26-0.73
-2.70%
Halliburton Company
INDI3.41-0.50
-12.79%
indie Semiconductor